标题
Serum Biomarkers for the Prediction of Hepatocellular Carcinoma
作者
关键词
-
出版物
Cancers
Volume 13, Issue 7, Pages 1681
出版商
MDPI AG
发表日期
2021-04-02
DOI
10.3390/cancers13071681
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Epidemiology and surveillance for hepatocellular carcinoma: New trends
- (2020) Amit G. Singal et al. JOURNAL OF HEPATOLOGY
- OPN is a promising serological biomarker for hepatocellular carcinoma diagnosis
- (2020) Mingyu Zhu et al. JOURNAL OF MEDICAL VIROLOGY
- Common and Unique microRNAs in Multiple Carcinomas Regulate Similar Network of Pathways to Mediate Cancer Progression
- (2020) Divya Niveditha et al. Scientific Reports
- A panel of five plasma proteins for the early diagnosis of hepatitis B virus-related hepatocellular carcinoma in individuals at risk
- (2020) Kai Cheng et al. EBioMedicine
- Serum Exosomal MicroRNA, miR-10b-5p, as a Potential Diagnostic Biomarker for Early-Stage Hepatocellular Carcinoma
- (2020) Hyo Jung Cho et al. Journal of Clinical Medicine
- Biomarkers for the Early Detection of Hepatocellular Carcinoma
- (2020) Neehar D Parikh et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Serum Levels of Alpha Fetoprotein Increased More Than 10 Years Before Detection of Hepatocellular Carcinoma.
- (2020) David M. Hughes et al. Clinical Gastroenterology and Hepatology
- MicroRNA signature in hepatocellular carcinoma patients: identification of potential markers
- (2020) Mohammed Elhendawy et al. MOLECULAR BIOLOGY REPORTS
- Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint
- (2020) Jörg Wischhusen et al. Frontiers in Immunology
- The diagnostic value of the combination of Golgi protein 73, glypican-3 and alpha-fetoprotein in hepatocellular carcinoma: a diagnostic meta-analysis
- (2020) Shoujie Zhao et al. Annals of Translational Medicine
- Exosomal microRNA‐4661‐5p–based serum panel as a potential diagnostic biomarker for early‐stage hepatocellular carcinoma
- (2020) Hyo Jung Cho et al. Cancer Medicine
- Plasma Small Extracellular Vesicles Derived miR-21-5p and miR-92a-3p as Potential Biomarkers for Hepatocellular Carcinoma Screening
- (2020) Andrei Sorop et al. Frontiers in Genetics
- A global investment framework for the elimination of hepatitis B
- (2020) Jessica Howell et al. JOURNAL OF HEPATOLOGY
- IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells
- (2020) Yu Li et al. OncoTargets and Therapy
- New advances in the diagnosis and management of hepatocellular carcinoma
- (2020) Ju Dong Yang et al. BMJ-British Medical Journal
- Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection
- (2020) Huan Deng et al. Scientific Reports
- A Large-Scale Multicenter Study Validates AKR1B10 as a New Prevalent Serum Marker for Detection of Hepatocellular Carcinoma
- (2019) Xu Ye et al. HEPATOLOGY
- From NASH to HCC: current concepts and future challenges
- (2019) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Hepatocellular Carcinoma
- (2019) Augusto Villanueva NEW ENGLAND JOURNAL OF MEDICINE
- Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
- (2019) Yu Jin et al. Scientific Reports
- Research advances in the detection of miRNA
- (2019) Jiawei Ye et al. Journal of Pharmaceutical Analysis
- Circulating microRNA-301 as a promising diagnostic biomarker of hepatitis C virus-related hepatocellular carcinoma
- (2019) Moamena S. El-Hamouly et al. MOLECULAR BIOLOGY REPORTS
- Comprehensive transcriptomic analyses of tissue, serum, and serum exosomes from hepatocellular carcinoma patients
- (2019) Robin Mjelle et al. BMC CANCER
- GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis
- (2019) Jan Best et al. Clinical Gastroenterology and Hepatology
- Levels of Cytokines in Serum Associate With Development of Hepatocellular Carcinoma in Patients With HCV Infection Treated With Direct-Acting Antivirals
- (2018) Jose D. Debes et al. GASTROENTEROLOGY
- Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis
- (2018) Kristina Tzartzeva et al. GASTROENTEROLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients
- (2018) Noha Mohamed Hosni Shaheen et al. VIRUS RESEARCH
- Novel serum microRNAs panel on the diagnostic and prognostic implications of hepatocellular carcinoma
- (2018) Yang An et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The role of osteopontin in the progression of solid organ tumour
- (2018) Hailin Zhao et al. Cell Death & Disease
- Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma
- (2018) Farzaneh Moshiri et al. Oncotarget
- Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma
- (2018) Yurong Wang et al. Cancer Medicine
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Longitudinal Assessment of Three Serum Biomarkers to Detect Very Early Stage Hepatocellular Carcinoma
- (2018) Jonggi Choi et al. HEPATOLOGY
- Development and validation of serum exosomal microRNAs as diagnostic and prognostic biomarkers for hepatocellular carcinoma
- (2018) Xiaofeng Xue et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Therapeutic implication of vascular endothelial growth factor receptor-1 (VEGFR-1) targeting in cancer cells and tumor microenvironment by competitive and non-competitive inhibitors
- (2018) Pedro Miguel Lacal et al. PHARMACOLOGICAL RESEARCH
- LCR1 and LCR2, two multi-analyte blood tests to assess liver cancer risk in patients without or with cirrhosis
- (2018) Thierry Poynard et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Performance of Serum Glypican 3 in Diagnosis of Hepatocellular Carcinoma: A meta-analysis
- (2018) Dahai Xu et al. Annals of Hepatology
- GALAD Score for Hepatocellular Carcinoma Detection in Comparison to Liver Ultrasound and Proposal of GALADUS Score
- (2018) Ju Dong Yang et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- AASLD guidelines for the treatment of hepatocellular carcinoma
- (2017) Julie K. Heimbach et al. HEPATOLOGY
- High plasma interleukin-6 levels associated with poor prognosis of patients with advanced hepatocellular carcinoma
- (2017) Yu-Yun Shao et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- A randomized controlled trial of US vs US + biomarkers for the diagnosis of hepatocellular carcinoma: an interim report
- (2017) M. Sherman et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy
- (2017) Jose D. Debes et al. LIVER INTERNATIONAL
- Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patients
- (2017) Moustafa Nouh Elemeery et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma
- (2017) Bao-Min Shi et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Serum microRNA signatures and metabolomics have high diagnostic value in hepatocellular carcinoma
- (2017) Hai-Ning Liu et al. Oncotarget
- Comparison of miRNA quantitation by Nanostring in serum and plasma samples
- (2017) Catherine Foye et al. PLoS One
- Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis
- (2016) David S. Goldberg et al. HEPATOLOGY
- Patient-reported barriers are associated with lower hepatocellular carcinoma surveillance rates in patients with cirrhosis
- (2016) Sherean Farvardin et al. HEPATOLOGY
- Mechanisms of HBV-induced hepatocellular carcinoma
- (2016) Massimo Levrero et al. JOURNAL OF HEPATOLOGY
- Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma
- (2016) Roslyn Vongsuvanh et al. PLoS One
- Serum miR-21, miR-26a and miR-101 as potential biomarkers of hepatocellular carcinoma
- (2016) Chunbo Zhuang et al. Clinics and Research in Hepatology and Gastroenterology
- Enhanced circulating transforming growth factor beta 1 is causally associated with an increased risk of hepatocellular carcinoma: a mendelian randomization meta-analysis
- (2016) Wei-Qun LU et al. Oncotarget
- Diagnostic and Prognostic Roles of Serum Osteopontin and Osteopontin Promoter Polymorphisms in Hepatitis B-related Hepatocellular Carcinoma
- (2015) Nitinan Chimparlee et al. Asian Pacific Journal of Cancer Prevention
- Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma
- (2015) M Sadeghi et al. BRITISH JOURNAL OF CANCER
- A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study
- (2015) Xue-Jia Lin et al. LANCET ONCOLOGY
- Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?
- (2015) Pia Edenvik et al. LIVER INTERNATIONAL
- Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma
- (2015) Tianxiang Ge et al. MEDICAL ONCOLOGY
- Circulating MicroRNAs as Biomarkers in Hepatocellular Carcinoma Screening
- (2015) Li Jiang et al. MEDICINE
- Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients
- (2015) Tarek K. Motawi et al. PLoS One
- Circulating microRNAs: Emerging Biomarkers of Liver Disease
- (2015) Marco Arrese et al. SEMINARS IN LIVER DISEASE
- Circulating miR-375 and miR-199a-3p as potential biomarkers for the diagnosis of hepatocellular carcinoma
- (2015) Jian Yin et al. TUMOR BIOLOGY
- Serum miR-224 Reflects Stage of Hepatocellular Carcinoma and Predicts Survival
- (2015) Li-ping Zhuang et al. Biomed Research International
- Su2042 Serum VEGF as a Tumor Marker for Patients With HCV-Related Liver Cirrhosis and Hepatocellular Carcinoma
- (2015) Takanori Mukozu et al. GASTROENTEROLOGY
- Association of Serum Level of Growth Differentiation Factor 15 with Liver Cirrhosis and Hepatocellular Carcinoma
- (2015) Xiuying Liu et al. PLoS One
- Osteopontin and latent-TGF β binding-protein 2 as potential diagnostic markers for HBV-related hepatocellular carcinoma
- (2014) Andre Nogueira da Costa et al. INTERNATIONAL JOURNAL OF CANCER
- The Detection of Hepatocellular Carcinoma Using a Prospectively Developed and Validated Model Based on Serological Biomarkers
- (2013) P. J. Johnson et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Evaluation of circulating Transforming growth factor-beta1, Glypican-3 and Golgi protein-73 mRNAs expression as predictive markers for hepatocellular carcinoma in Egyptian patients
- (2013) Gehan H. Ibrahim et al. MOLECULAR BIOLOGY REPORTS
- Performance of serum α-fetoprotein levels in the diagnosis of hepatocellular carcinoma in patients with a hepatic mass
- (2013) Stephen L. Chan et al. HPB
- Circulating miRNAs: cell–cell communication function?
- (2013) A. Turchinovich et al. Frontiers in Genetics
- Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3
- (2011) Runqiu Jiang et al. HEPATOLOGY
- Identification of osteopontin as a novel marker for early hepatocellular carcinoma
- (2011) Sufen Shang et al. HEPATOLOGY
- Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma
- (2011) Yoshito Tomimaru et al. JOURNAL OF HEPATOLOGY
- Serum levels of β-catenin as a potential marker for genotype 4/hepatitis C-associated hepatocellular carcinoma
- (2011) Sayed Daoud ONCOLOGY REPORTS
- Causes and consequences of microRNA dysregulation in cancer
- (2009) Carlo M. Croce NATURE REVIEWS GENETICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started